Merck (ETR:MRK) target price increased to 101.00EUR, issued a ratings update today by Commerzbank AG
- Updated: October 16, 2016
Yesterday Merck (ETR:MRK) traded -0.59% lower at 97.63EUR. The company’s 50-day moving average is 62.56EUR and its 200-day moving average is 58.70EUR. The last closing price is up 5.86% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. 12,204,208 shares of the stock were exchanged, up from an avg. volume of 10,128,900
In a report released on Monday October 17, 2016 Commerzbank AG increased the stock price target of Merck (ETR:MRK) to 101.00EUR indicating a possible upside of 0.03%.
Previously on 10/16/2016, Joh. Berenberg Gossler & Co. KG reported on Merck (ETR:MRK) increased the target price from 0.00EUR to 101.00EUR. At the time, this indicated a possible upside of 0.03%.
With a total market value of 0 EUR, Merck has price-earnings ratio of 34.09 with a one year low of 47.97EUR and a one year high of 64.86EUR .
A total of 20 equity analysts have released a ratings update on MRK. Two equity analysts rating the company a strong buy, seven equity analysts rating the company a buy, thirteen equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of 61.60EUR.
Brief Synopsis About Merck (ETR:MRK)
Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.